DRI Healthcare Trust T.DHT.UN

Some news...progressing

[hoffbag]

DRI Healthcare Trust Announces Acquisition of Royalty on Oracea®

“We are very pleased to announce the addition of Oracea to our portfolio,” said Behzad Khosrowshahi, Chief Executive Officer of DRI Healthcare Trust. “It has an established commercial track record and is among the top available treatment options for managing papulopustular rosacea, which can have a substantial negative quality of life impact. This transaction is expected to be immediately accretive to the Trust and further benefits unitholders through diversification of DRI’s portfolio by therapeutic area and marketer.”